Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan

NCT03185832 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03185832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
July 21, 2017
Completion date
December 1, 2020
Enrollment
354 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, heart failure, sudden cardiac death